RhumbLine Advisers Portfolio holdings
AUM
$117B
This Quarter Return
+0.47%
1 Year Return
+24.59%
3 Year Return
+106.81%
5 Year Return
+195.15%
10 Year Return
+469.64%
AUM
$31.4B
AUM Growth
+$31.4B
(-9.5%)
Cap. Flow
-$3.03B
Cap. Flow
% of AUM
-9.65%
Top 10 Holdings %
Top 10 Hldgs %
14.1%
Holding
3,232
New
197
Increased
1,229
Reduced
1,602
Closed
193
Top Buys
| 1 |
Starbucks
SBUX
|
$46.9M |
| 2 |
Ross Stores
ROST
|
$19.9M |
| 3 |
CF Industries
CF
|
$19.7M |
| 4 |
PPG Industries
PPG
|
$18.4M |
| 5 |
Aptiv
APTV
|
$16.7M |
Top Sells
| 1 |
Apple
AAPL
|
$211M |
| 2 |
Microsoft
MSFT
|
$97.5M |
| 3 |
Exxon Mobil
XOM
|
$81.1M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$70.5M |
| 5 |
Johnson & Johnson
JNJ
|
$66.9M |
Sector Composition
| 1 | Financials | 15.19% |
| 2 | Healthcare | 14.93% |
| 3 | Technology | 14.49% |
| 4 | Industrials | 10.71% |
| 5 | Consumer Discretionary | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Merck
MRK
$210B
| $199M | 0.63% |
3,494,425
-695,367
| -17% | -$39.6M |
|
27
PepsiCo
PEP
$204B
| $198M | 0.63% |
2,119,058
-418,210
| -16% | -$39M |
|
28
Cisco
CSCO
$274B
| $195M | 0.62% |
7,089,830
-1,159,439
| -14% | -$31.8M |
|
29
Oracle
ORCL
$635B
| $186M | 0.59% |
4,604,697
-905,810
| -16% | -$36.5M |
|
30
Visa
V
$683B
| $181M | 0.58% |
2,699,379
-519,047
| -16% | -$34.9M |
|
31
UnitedHealth
UNH
$281B
| $176M | 0.56% |
1,440,623
-191,878
| -12% | -$23.4M |
|
32
CVS Health
CVS
$92.8B
| $172M | 0.55% |
1,639,490
-242,891
| -13% | -$25.5M |
|
33
Amgen
AMGN
$155B
| $171M | 0.54% |
1,111,329
-171,188
| -13% | -$26.3M |
|
34
AbbVie
ABBV
$372B
| $163M | 0.52% |
2,425,320
-250,511
| -9% | -$16.8M |
|
35
Walmart
WMT
$774B
| $157M | 0.5% |
2,207,941
-371,864
| -14% | -$26.4M |
|
36
3M
MMM
$82.8B
| $152M | 0.49% |
987,833
-170,857
| -15% | -$26.4M |
|
37
Philip Morris
PM
$260B
| $152M | 0.48% |
1,896,854
-378,039
| -17% | -$30.3M |
|
38
Qualcomm
QCOM
$173B
| $145M | 0.46% |
2,319,767
-522,266
| -18% | -$32.7M |
|
39
Bristol-Myers Squibb
BMY
$96B
| $145M | 0.46% |
2,173,716
-327,639
| -13% | -$21.8M |
|
40
Schlumberger
SLB
$55B
| $142M | 0.45% |
1,642,603
-329,022
| -17% | -$28.4M |
|
|
AGN
41
DELISTED
Allergan plc
AGN
| $141M | 0.45% |
465,114
-96,883
| -17% | -$29.4M |
|
42
Medtronic
MDT
$119B
| $140M | 0.45% |
1,892,402
-386,604
| -17% | -$28.6M |
|
43
Biogen
BIIB
$19.4B
| $135M | 0.43% |
334,433
-56,632
| -14% | -$22.9M |
|
44
McDonald's
MCD
$224B
| $134M | 0.43% |
1,404,403
-254,399
| -15% | -$24.2M |
|
45
Mastercard
MA
$538B
| $132M | 0.42% |
1,415,634
-269,352
| -16% | -$25.2M |
|
|
CELG
46
DELISTED
Celgene Corp
CELG
| $128M | 0.41% |
1,104,995
-199,638
| -15% | -$23.1M |
|
47
Boeing
BA
$177B
| $123M | 0.39% |
884,902
-196,240
| -18% | -$27.2M |
|
48
Union Pacific
UNP
$133B
| $120M | 0.38% |
1,255,146
-252,775
| -17% | -$24.1M |
|
49
RTX Corp
RTX
$212B
| $118M | 0.38% |
1,066,529
-210,977
| -17% | -$23.4M |
|
50
Goldman Sachs
GS
$226B
| $117M | 0.37% |
558,421
-104,843
| -16% | -$21.9M |
|